Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP17A1 | P05093 | 2/20 | 0.85 |
| ▸ | SERPINA6 | P08185 | 6/20 | 0.62 |
| ▸ | SHBG | P04278 | 7/20 | 0.60 |
| ▸ | LMNA | P02545 | 6/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.60 |
| ▸ | BLM | P54132 | 4/20 | 0.60 |
| ▸ | NR3C1 | P04150 | 3/20 | 0.60 |
| ▸ | MAPT | P10636 | 3/20 | 0.60 |
| ▸ | MEN1 | O00255 | 2/20 | 0.60 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | MAPK3 | P27361 | 1/20 | 0.60 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | PGR | P06401 | 2/20 | 0.56 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.56 |
| ▸ | HTR2B | P41595 | 2/20 | 0.56 |
| ▸ | TSHR | P16473 | 5/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4539514 | 0.92 | CYP17A1 (1.00) | CYP17A1SERPINA6SHBGLMNASMN1; SMN2 | |
| SCHEMBL29500568 | 0.92 | CYP17A1 (1.00) | CYP17A1SERPINA6SHBGLMNASMN1; SMN2 | |
| SCHEMBL4541005 | 0.92 | CYP17A1 (1.00) | CYP17A1SERPINA6SHBGLMNASMN1; SMN2 | |
| SCHEMBL7993136 | 0.92 | CYP17A1 (1.00) | CYP17A1SERPINA6SHBGLMNASMN1; SMN2 | |
| SCHEMBL29409283 | 0.92 | CYP17A1 (1.00) | CYP17A1SERPINA6SHBGLMNASMN1; SMN2 | |
| Algestone Acetophenide SCHEMBL3039564 | 0.87 | CYP17A1 (0.76) | CYP17A1SERPINA6SHBGLMNASMN1; SMN2 | |
| Algestone Acetophenide SCHEMBL1649218 | 0.87 | CYP17A1 (0.76) | CYP17A1SERPINA6SHBGLMNASMN1; SMN2 | |
| Algestone Acetophenide SCHEMBL282250 | 0.87 | CYP17A1 (0.76) | CYP17A1SERPINA6SHBGLMNASMN1; SMN2 | |
| SCHEMBL6024700 | 0.86 | CYP17A1 (0.63) | CYP17A1SERPINA6SHBGLMNASMN1; SMN2 | |
| SCHEMBL11880147 | 0.85 | HIF1A (0.62) | CYP17A1SERPINA6SHBGLMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2757 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4290465-B1 | 3D OBJECT STREAMING METHOD, DEVICE, AND PROGRAM | MAWARI CORP (US) | 2026-03-11 | — | — | EP | claimed |
| EP-3943073-B1 | BIODEGRADABLE POLYMER MICROPARTICLE CONTAINING STEROID-BASED DRUG AND PREPARATION METHOD THEREFOR | REGENBIOTECH INC (KR) | 2025-03-26 | — | — | EP | claimed |
| EP-4183886-B1 | METHOD FOR NUCLEIC ACID AMPLIFICATION | ST JUDE CHILDRENS RES HOSPITAL INC (US) | 2024-04-17 | — | — | EP | claimed |
| CN-117825542-A | Marker composition for hemoglobinopathy, screening reagent and application thereof | 重庆医科大学附属儿童医院 | 2024-04-05 | — | — | CN | claimed |
| EP-4335413-A2 | PROSTHETIC TISSUE VALVES | Cormatrix Cardiovascular, Inc. (US) | 2024-03-13 | — | — | EP | claimed |
| CN-117202431-B | LED lamp dynamic control system based on Internet of things | 上海升美电子科技有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-117202431-A | LED lamp dynamic control system based on Internet of things | 上海升美电子科技有限公司 | 2023-12-08 | — | — | CN | claimed |
| WO-2023212179-A2 | THERAPEUTIC COMPOSITIONS FOR SKIN DISORDERS AND WOUND REPAIR | UNIVERSITY OF MIAMI (US) | 2023-11-02 | — | — | WO | claimed |
| EP-4013420-B1 | METHOD OF BLOCKING OR AMELIORATING CYTOKINE RELEASE SYNDROME | RIGEL PHARMACEUTICALS INC (US) | 2023-11-01 | — | — | EP | claimed |
| EP-4013136-B1 | UPLINK POWER ADJUSTMENT METHOD AND RELATED DEVICE | GUANGDONG OPPO MOBILE TELECOMMUNICATIONS CORP LTD (CN) | 2023-06-07 | — | — | EP | claimed |
| WO-2003088811-A2 | GELSOLIN AS A PROGNOSTIC MARKER OF ARTHEROSCLEROTIC DISEASES | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2003-10-30 | — | — | WO | claimed |
| US-20030152566-A1 | Soluble CD40L (CD154) as a prognostic marker of atherosclerotic diseases | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2003-08-14 | — | — | US | claimed |
| WO-2003040691-A2 | SOLUBLE CD40L(CD154) AS A PROGNOSTIC MARKER OF ATHEROSCLEROTIC DISEASES | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2003-05-15 | — | — | WO | claimed |
| WO-2001015744-A9 | SYSTEMIC INFLAMMATORY MARKERS AS DIAGNOSTIC TOOLS IN THE PREVENTION OF ATHEROSCLEROTIC DISEASES | BRIGHAM & WOMENS HOSPITAL (US) | 2002-09-26 | — | — | WO | claimed |
| EP-1212101-A1 | SYSTEMIC INFLAMMATORY MARKERS AS DIAGNOSTIC TOOLS IN THE PREVENTION OF ATHEROSCLEROTIC DISEASES | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2002-06-12 | — | — | EP | claimed |
| JP-2001525058-A | — | — | 2001-12-04 | — | — | JP | claimed |
| WO-2001015744-A1 | SYSTEMIC INFLAMMATORY MARKERS AS DIAGNOSTIC TOOLS IN THE PREVENTION OF ATHEROSCLEROTIC DISEASES | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2001-03-08 | — | — | WO | claimed |
| EP-1003501-A4 | MEANS OF ASCERTAINING AN INDIVIDUAL'S RISK PROFILE FOR ATHEROSCLEROTIC DISEASE | BRIGHAM & WOMENS HOSPITAL (US) | 2001-01-17 | — | — | EP | claimed |
| EP-1003501-A1 | MEANS OF ASCERTAINING AN INDIVIDUAL'S RISK PROFILE FOR ATHEROSCLEROTIC DISEASE | BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2000-05-31 | — | — | EP | claimed |
| WO-1998043630-A1 | MEANS OF ASCERTAINING AN INDIVIDUAL'S RISK PROFILE FOR ATHEROSCLEROTIC DISEASE | BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 1998-10-08 | — | — | WO | claimed |